rs61748422

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001110792.2(MECP2):​c.731G>C​(p.Gly244Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000558 in 1,206,746 control chromosomes in the GnomAD database, including 8 homozygotes. There are 214 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., 8 hem., cov: 23)
Exomes 𝑓: 0.00059 ( 8 hom. 206 hem. )

Consequence

MECP2
NM_001110792.2 missense

Scores

1
4
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.58
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00890398).
BP6
Variant X-154031133-C-G is Benign according to our data. Variant chrX-154031133-C-G is described in ClinVar as [Benign]. Clinvar id is 143661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154031133-C-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000253 (28/110714) while in subpopulation EAS AF= 0.00718 (25/3482). AF 95% confidence interval is 0.00499. There are 0 homozygotes in gnomad4. There are 8 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 8 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MECP2NM_001110792.2 linkc.731G>C p.Gly244Ala missense_variant Exon 3 of 3 ENST00000453960.7 NP_001104262.1 P51608-2A0A140VKC4Q59FJ6
MECP2NM_004992.4 linkc.695G>C p.Gly232Ala missense_variant Exon 4 of 4 ENST00000303391.11 NP_004983.1 P51608-1D3YJ43Q59FJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkc.731G>C p.Gly244Ala missense_variant Exon 3 of 3 1 NM_001110792.2 ENSP00000395535.2 P51608-2
MECP2ENST00000303391.11 linkc.695G>C p.Gly232Ala missense_variant Exon 4 of 4 1 NM_004992.4 ENSP00000301948.6 P51608-1

Frequencies

GnomAD3 genomes
AF:
0.000253
AC:
28
AN:
110662
Hom.:
0
Cov.:
23
AF XY:
0.000243
AC XY:
8
AN XY:
32912
show subpopulations
Gnomad AFR
AF:
0.0000330
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000949
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00716
Gnomad SAS
AF:
0.000392
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000185
AC:
34
AN:
183387
Hom.:
0
AF XY:
0.000206
AC XY:
14
AN XY:
67859
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00188
Gnomad SAS exome
AF:
0.000262
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000662
GnomAD4 exome
AF:
0.000588
AC:
645
AN:
1096032
Hom.:
8
Cov.:
36
AF XY:
0.000570
AC XY:
206
AN XY:
361712
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0205
Gnomad4 SAS exome
AF:
0.000259
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000261
GnomAD4 genome
AF:
0.000253
AC:
28
AN:
110714
Hom.:
0
Cov.:
23
AF XY:
0.000243
AC XY:
8
AN XY:
32974
show subpopulations
Gnomad4 AFR
AF:
0.0000329
Gnomad4 AMR
AF:
0.0000948
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00718
Gnomad4 SAS
AF:
0.000393
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000868
Hom.:
1
Bravo
AF:
0.000113
ExAC
AF:
0.000198
AC:
24

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 10, 2010
RettBASE
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: curation

- -

May 03, 2017
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Severe neonatal-onset encephalopathy with microcephaly Benign:1
Oct 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Rett syndrome Benign:1
Aug 14, 2023
Centre for Population Genomics, CPG
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria.Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 2.0 (BA1). The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2). -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 30564305) -

MECP2-related disorder Benign:1
May 25, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.070
CADD
Benign
20
DANN
Benign
0.84
DEOGEN2
Benign
0.27
T;.;T;T
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.87
D;D;D;D
M_CAP
Pathogenic
0.70
D
MetaRNN
Benign
0.0089
T;T;T;T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
0.55
N;.;.;.
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.55
N;N;.;.
REVEL
Uncertain
0.38
Sift
Benign
0.19
T;T;.;.
Sift4G
Benign
0.58
T;T;.;T
Polyphen
0.023
B;B;.;.
Vest4
0.10
MVP
0.99
ClinPred
0.022
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.16
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61748422; hg19: chrX-153296584; API